Skip to main content
. 2022 Dec 29;15(1):217. doi: 10.3390/cancers15010217

Figure 6.

Figure 6

SP treatment reduces GBM tumor growth via PPAR-γ signaling. (A) No weight differences were observed between animals treated with SP at a dose of 10, 30, or 100 mg/kg in the GBM group and SP (10, 30 and 100 mg/kg) + GW9661 1 mg/kg groups. (B) Representative images of tumor mass appearance from mice subjected to the xenograft model of GBM. (C,D) A reduction in tumor weight and tumor burden was observed after SP treatments at doses of 30 mg/kg and 100 mg/kg compared to the GBM mice while administration of GW9662 showed no significant differences compared to the GBM mice. *** p < 0.001 vs. GBM.